What is the antidote for a beta blocker overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Beta Blocker Overdose Antidote Management

High-dose insulin is the recommended first-line antidote for beta blocker overdose, followed by glucagon and vasopressors for refractory cases. 1

First-Line Therapies

High-Dose Insulin Therapy

  • Strongest recommendation (Class 1, Level B-NR) for hypotension due to beta blocker poisoning 1
  • Dosing protocol:
    • Initial bolus: 1 U/kg regular insulin IV
    • Maintenance: 0.5-1 U/kg/hour continuous infusion
    • Concurrent dextrose: 0.5 g/kg bolus followed by 0.5 g/kg/hour infusion
    • Titrate insulin to hemodynamic response
    • Titrate dextrose to maintain glucose 100-250 mg/dL 1
  • Monitor glucose frequently (every 15 minutes initially)
  • Monitor potassium levels; target moderate hypokalemia (2.5-2.8 mEq/L) 1
  • Benefits: Improves inotropy with fewer vasoconstrictive complications than vasopressor-only therapy 1

Vasopressors

  • Strong recommendation (Class 1, Level C-LD) for hypotension 1
  • Often used as initial therapy due to immediate availability and rapid action
  • May be used concurrently with high-dose insulin

Second-Line Therapies

Glucagon

  • Reasonable to use (Class 2a, Level C-LD) for bradycardia or hypotension 1
  • Mechanism: Activates adenylate cyclase through a beta-receptor independent pathway 2
  • Dosing:
    • Bolus: 3-10 mg IV (0.05-0.15 mg/kg) administered slowly over 3-5 minutes
    • Maintenance: 3-5 mg/hour (0.05-0.10 mg/kg/hour) infusion 1
    • Titrate to hemodynamic response
  • Important considerations:
    • Ensure adequate supply (may require >100 mg over 24 hours) 1
    • Common side effect: vomiting (protect airway in CNS-depressed patients) 1
    • Effectiveness confirmed in clinical studies regardless of beta-blockade 3

Third-Line Therapies

Calcium

  • May be reasonable (Class 2b, Level C-LD) for refractory shock 1
  • Dosing:
    • Initial: 0.3 mEq/kg (0.6 mL/kg of 10% calcium gluconate or 0.2 mL/kg of 10% calcium chloride) IV over 5-10 minutes
    • Maintenance: 0.3 mEq/kg/hour infusion 1
    • Titrate to hemodynamic response
    • Monitor ionized calcium levels (avoid levels >2× upper limit of normal)
  • Requires central venous access for sustained infusion

Electrical Pacing

  • May be reasonable (Class 2b, Level C-LD) for beta blocker-induced bradycardia 1

Hemodialysis

  • May be reasonable (Class 2b, Level C-LD) specifically for atenolol or sotalol poisoning 1

Refractory Cases

VA-ECMO (Veno-Arterial Extracorporeal Membrane Oxygenation)

  • Reasonable to use (Class 2a, Level C-LD) for life-threatening beta blocker poisoning with cardiogenic shock refractory to pharmacological interventions 1
  • Consider early if patient shows signs of deterioration despite maximal medical therapy

Therapies Not Recommended

Intravenous Lipid Emulsion

  • Not likely to be beneficial (Class 3: No Benefit, Level C-LD) for life-threatening beta blocker poisoning 1

Clinical Pearls and Pitfalls

  1. Early recognition is critical: Beta blocker overdose presents with bradycardia, hypotension, and cardiogenic shock 1, 2

  2. Monitoring considerations:

    • Frequent glucose monitoring is essential during insulin therapy
    • Moderate hypokalemia is expected and should not prompt aggressive repletion 1
    • Central venous access is needed for sustained calcium or concentrated dextrose infusions
  3. Treatment escalation:

    • Begin with vasopressors for immediate effect
    • Rapidly initiate high-dose insulin therapy
    • Add glucagon if response is inadequate
    • Consider calcium for refractory cases
    • Early consideration of VA-ECMO for deteriorating patients
  4. Special considerations:

    • Glucagon may interact with beta-blockers, causing transient increases in pulse and blood pressure 4
    • Ensure adequate glucagon supply before initiating therapy
    • Protect airway before glucagon administration in patients with CNS depression

By following this algorithmic approach to beta blocker overdose management, clinicians can optimize patient outcomes in these potentially fatal poisonings.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cardiovascular Toxicity of Beta Blockers and Calcium Channel Blockers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.